Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Apr 09, 2013 |
President & CEO
|
President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 52,885 | -- | -- |
Feb 22, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 55,711 | -- | 558,680 |
Nov 15, 2022 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 57,952 | $11.43 | 652,334 |
Feb 20, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,963 | -- | 396,509 |
Feb 19, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 62,053 | $16.76 | 335,546 |
Feb 18, 2009 |
President & COO
|
President & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,607 | -- | 67,607 |
Feb 21, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 73,459 | $10.50 | 765,938 |
Feb 15, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 84,270 | -- | 803,704 |
Feb 21, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 85,152 | -- | 839,397 |
Feb 23, 2011 |
President & COO
|
President & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 91,287 | -- | 91,287 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.